|
π
|
BHIVA/BASHH guidelines on the use of HIV preβexposure prophylaxis (PrEP) 2018
16 auth.
M. Brady,
A. Rodger,
D. Asboe,
V. Cambiano,
D. Clutterbuck,
M. Desai,
N. Field,
J. Harbottle,
Z. Jamal,
S. McCormack,
...
A. Palfreeman,
Mags D Portman,
K. Quinn,
M. TenantβFlowers,
E. Wilkins,
Ingrid Young
|
6 |
2019 |
6
π
|
|
π
|
A Comparative Phase I Study of Combination, Homologous Subtype-C DNA, MVA, and Env gp140 Protein/Adjuvant HIV Vaccines in Two Immunization Regimes
22 auth.
S. Joseph,
K. Quinn,
A. Greenwood,
A. Cope,
P. McKay,
P. Hayes,
J. Kopycinski,
J. Gilmour,
A. Miller,
C. Geldmacher,
...
Y. Nadai,
Mohamed I. M. Ahmed,
D. Montefiori,
L. Dally,
G. Bouliotis,
D. Lewis,
R. Tatoud,
R. Wagner,
M. Esteban,
R. Shattock,
S. McCormack,
J. Weber
|
4 |
2017 |
4
π
|
|
π
|
Genetic Variants of APOL1 Are Major Determinants of Kidney Failure in People of African Ancestry With HIV
197 auth.
R. Hung,
Elizabeth A. Binns-Roemer,
John W. Booth,
Rachel Hilton,
M. Harber,
Beatriz Santana-Suarez,
Lucy Campbell,
Julie Fox,
A. Ustianowski,
Catherine Cosgrove,
James E. Burns,
Amanda Clarke,
David A. Price,
David Chadwick,
D. Onyango,
...
Lisa Hamzah,
K. Bramham,
C. Sabin,
C. Winkler,
F. Post,
John W. Booth,
A. Waters,
J. Hand,
C. Clarke,
S. Murphy,
M. Murphy,
M. Campbell,
Amanda Clarke,
C. Richardson,
Alyson Knott,
G. Weir,
Rebecca Cleig,
Helena Soviarova,
Lisa Barbour,
Tanya Adams,
Vicky Kennard,
Vittorio Trevitt,
Rachael Jones,
J. Levy,
Alexandra Schoolmeester,
Serah Duro,
Rachel Hilton,
Julie Fox,
M. Rabuya,
Lisa Hamzah,
D. Jordan,
T. Solano,
H. Uzu,
Karen S Williams,
J. Lwanga,
Linda Ekaette Reid-Amoruso,
H. Gamlen,
Rob Stocker,
F. Ryan,
Karina Mahiouz,
T. Cheetham,
Claire E. Williams,
A. Nori,
C. Thomas,
S. Venkateshwaran,
Jessica Doctor,
Andrea Berlanga,
F. Post,
Beatriz Santana-Suarez,
L. McQueen,
Priya Bhagwandin,
Lucy Campbell,
Bee Barbini,
Emily Wandolo,
Timothy Appleby,
Lois Driver,
Sophy Parr,
Hongbo Deng,
J. Barber,
Andrew Crowe,
Chris Taylor,
M. Poulton,
Vida Boateng,
M. Klein,
C. OβBrien,
Samuel Ohene-Adomako,
Christian Buckingham,
D. Trotman,
K. Quinn,
Kate Flanagan,
Verity Sullivan,
H. Middleditch,
I. Samuel,
E. Hamlyn,
C. Mcdonald,
A. Canoso,
E. Agbasi,
M. LiΕ‘kovΓ‘,
S. Barber,
A. Samarawickrama,
Zoe Ottaway,
C. Norcross,
Amelia Oliveira,
K. Bramham,
J. Minton,
Gary Lamont,
Ruby Cross,
Gaushiya Saiyad,
Shadia K. Ahmed,
R. Ashworth,
N. Window,
J. Murira,
K. Phyu,
A. Ustianowski,
G. Lindergard,
Jonathan Shaw,
Sarah Holland,
C. Fox,
J. Flaherty,
Margaret-Anne Bevan,
Valerie George,
David Chadwick,
M. Branch,
P. Lambert,
Adele Craggs,
S. Pett,
Hinal Lukha,
N. Vora,
M. Fiorino,
M. M. Nunez,
Deirdre Sally,
J. E. Burns,
Erica R M Pool,
R. Matthews,
David A. Price,
Tara Stothard,
Bijal Patel,
Ian McVittie,
Ciara Kennedy,
Uli Shwab,
B. Payne,
Sarah Duncan,
J. Dixon,
M. Schmid,
Adam Evans,
C. Duncan,
E. Hunter,
Yusri Taha,
N. Astill,
C. Winkler,
Elizabeth A. Binns-Roemer,
V. David,
J. Ainsworth,
R. Vincent,
S. Kegg,
C. Saad,
Sarah C. Skinner,
H. Azzoug,
J. Russell,
T. Moussaoui,
E. Mabonga,
Donna Ward,
J. Francoise,
W. Larbi,
S. Mitchell,
A. Manning,
V. Russell,
F. Burns,
M. Harber,
Nnenna Ngwu,
Jonathan Edwards,
Nargis Hemat,
T. Fernandez,
F. Ferro,
Jorge Ferreira,
A. Nightingale,
Tasha Oakes-Monger,
D. Matila,
P. Nogueira,
Victoria Mutagwanya,
Catherine Cosgrove,
C. Isitt,
H. Webb,
J. Popoola,
Kate Korley,
M. Mencias,
P. Ribeiro,
Rajeshwar Ramkhelawn,
Sandra Oliva Lara,
Sara Sajijad,
A. Winston,
A. Shaw,
C. Petersen,
K. Ring,
M. Rosenvinge,
T. Moyo,
Faith Odong,
K. Gantert,
Tina Ibe,
D. Onyango,
C. Sabin,
T. Hill
|
4 |
2022 |
4
π
|
|
π
|
Laboratory adverse events and discontinuation of therapy according to CD4+ cell count at the start of antiretroviral therapy
15 auth.
S. Jose,
K. Quinn,
T. Hill,
C. Leen,
J. Walsh,
P. Hay,
M. Fisher,
F. Post,
M. Nelson,
M. Gompels,
...
M. Johnson,
D. Chadwick,
R. Gilson,
C. Sabin,
S. Fidler
|
3 |
2014 |
3
π
|
|
π
|
BHIVA β BASHH Position Statement on PrEP in UK Second Update May 2016
26 auth.
S. McCormack,
S. Fidler,
L. Waters,
Y. Azad,
T. Barber,
G. Cairns,
V. Cambiano,
D. Clutterbuck,
M. Desai,
D. Dunn,
J. Fox,
Y. Gilleece,
M. Kingston,
C. Lacey,
H. L. Date,
...
F. Martin,
A. Mcowan,
A. Nardone,
K. Ong,
R. Pebody,
A. Phillips,
Mags D Portman,
K. Quinn,
I. Reeves,
A. Sullivan,
G. Valiotis
|
3 |
2016 |
3
π
|
|
π¦
|
A first-in-human study of the novel HIV-fusion inhibitor C34-PEG4-Chol
13 auth.
K. Quinn,
C. Traboni,
S. D. Penchala,
G. Bouliotis,
N. Doyle,
V. Libri,
S. Khoo,
D. Ashby,
J. Weber,
A. Nicosia,
...
R. Cortese,
A. Pessi,
A. Winston
|
3 |
2017 |
3
π¦
|
|
π
|
Developing a Bayesian adaptive design for a phase I clinical trial: a case study for a novel HIV treatment
9 auth.
A. Mason,
J. Gonzalez-Maffe,
K. Quinn,
N. Doyle,
K. Legg,
P. Norsworthy,
...
R. Trevelion,
A. Winston,
D. Ashby
|
3 |
2016 |
3
π
|
